Black Hawk Acquisition Corp
No SEC Form 4 filings for $BKHAR in the last 30 days.
See all $BKHAR insider activity →Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On September 22, 2026, Black Hawk Acquisition Corporation, a Cayman Islands exempted company (“BKHA” or the “Company”), and Vesicor Therapeutics, Inc., a California corporation (“Vesicor”), entered into a series of financing a
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Other Events. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 22, 2026 Black Hawk Acquisition Corporation (Exact Name of Registrant as Specified in i
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On August 21, 2026, Black Hawk Acquisition Corp., a Cayman Islands exempted company (the “Company”), issued a convertible promissory note (the “Note”) in the principal amount of up to $300,000 to Black Hawk Management LLC (the
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning BKHAR (Black Hawk Acquisition Corp). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.
Recent BKHAR coverage spans financial news and corporate actions.
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On September 22, 2026, Black Hawk Acquisition Corporation, a Cayman Islands exempted company (“BKHA” or the “Company”), and Vesicor Therapeutics, Inc., a California corporation (“Vesicor”), entered into a series of financing a
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Other Events. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 22, 2026 Black Hawk Acquisition Corporation (Exact Name of Registrant as Specified in i
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On August 21, 2026, Black Hawk Acquisition Corp., a Cayman Islands exempted company (the “Company”), issued a convertible promissory note (the “Note”) in the principal amount of up to $300,000 to Black Hawk Management LLC (the
This article provides a comprehensive overview of Black Hawk Acquisition Corp (BKHA) SEC filings, including 10-K, 10-Q, and 8-K forms, available on Stock Titan. It details several key filings, such as the proposed merger with Vesicor Therapeutics, extension payments to the trust account, notifications of late filings, and insider ownership disclosures. The platform also offers AI-powered summaries and sentiment analysis for each document to aid investor understanding.
This article provides detailed financial information and performance analysis for Black Hawk Acquisition Corporation (BKHA) on NASDAQ. It covers key statistics like market capitalization, P/E ratio, and basic EPS, along with technical indicators and historical price movements. The company is a blank check company founded on September 28, 2023, and the article also addresses frequently asked questions about its stock performance and financials.
AlphAI scores every news story that mentions BKHAR with an AI model for sentiment and relevance, and aggregates insider trades from Black Hawk Acquisition Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Black Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On September 22, 2026, Black Hawk Acquisition Corporation, a Cayman Islands exempted company (“BKHA” or the “Company”), and Vesicor Therapeutics, Inc., a California corporation (“Vesicor”), entered into a series of financing a
2 min readBlack Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Other Events. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 22, 2026 Black Hawk Acquisition Corporation (Exact Name of Registrant as Specified in i
1 min readBlack Hawk Acquisition Corp (BKHA) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. On August 21, 2026, Black Hawk Acquisition Corp., a Cayman Islands exempted company (the “Company”), issued a convertible promissory note (the “Note”) in the principal amount of up to $300,000 to Black Hawk Management LLC (the
1 min readThis article provides a comprehensive overview of Black Hawk Acquisition Corp (BKHA) SEC filings, including 10-K, 10-Q, and 8-K forms, available on Stock Titan. It details several key filings, such as the proposed merger with Vesicor Therapeutics, extension payments to the trust account, notifications of late filings, and insider ownership disclosures. The platform also offers AI-powered summaries and sentiment analysis for each document to aid investor understanding.
4 min readThis article provides detailed financial information and performance analysis for Black Hawk Acquisition Corporation (BKHA) on NASDAQ. It covers key statistics like market capitalization, P/E ratio, and basic EPS, along with technical indicators and historical price movements. The company is a blank check company founded on September 28, 2023, and the article also addresses frequently asked questions about its stock performance and financials.
3 min readBlack Hawk Acquisition Corporation (BKHA) has announced a sponsor-backed convertible note financing of up to $300,000 from Black Hawk Management LLC to cover working capital needs. The note bears 10% annual interest and matures upon the initial business combination or liquidation, with the sponsor having the option to receive cash repayment or convert the note into equity at $1.00 per share in a DeSPAC transaction. This flexible financing structure supports the SPAC's deal execution while aligning the sponsor's incentives with the combined company's future performance.
2 min readDANVILLE, Calif., July 07, 2025 ( GLOBE NEWSWIRE ) -- Black Hawk Acquisition Corporation ( NASDAQ: BKHAU, the "Company" ) announced today that it filed a supplement to its definitive proxy statement, originally filed with the Securities and Exchange Commission on June 10, 2025, to amend the ...
3 min readDANVILLE, Calif., June 20, 2025 ( GLOBE NEWSWIRE ) -- Black Hawk Acquisition Corporation BKHAU the "Company" ) ) announced today that it filed a supplement to its definitive proxy statement, originally file with the Securities and Exchange Commission on June 10, 2025, to amend the language of ...
2 min readDANVILLE, Calif., June 20, 2025 ( GLOBE NEWSWIRE ) -- Black Hawk Acquisition Corporation ( NASDAQ: BKHAU, the "Company" ) announced today that it filed a supplement to its definitive proxy statement, originally file with the Securities and Exchange Commission on June 10, 2025, to amend the ...
2 min readDANVILLE, Calif., April 28, 2025 ( GLOBE NEWSWIRE ) -- Black Hawk Acquisition Corp. ( Nasdaq: BKHAU, BKHA, BKHAR ) , a special purpose acquisition company, ( "Black Hawk" ) announced the signing of a Business Combination Agreement ( "BCA" ) on April 26, 2025, with Vesicor Therapeutics, Inc. ( ...
3 min read
